Clinical Trial Update: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of HS-20089 for ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and endometrial cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• HS-20089

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: RECRUITING